Agostinho FR, Rus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Benedet J, Rochi N, Scaini G, Streck EL, Quevedo J (2011) Treatment with olanzapine, fluoxetine and olanzapine/fluoxetine alters citrate synthase activity in rat brain
This observation aligns with the results of the MTT assay, suggesting that our treatment does not directly kill inflammatory cells but rather modulates their state to rescue cell damage
This design helps maintain metabolic balance but also explains why side effects can continue briefly after stopping treatment
CoA-LOT: BN20241018/CA
It mimics a gut hormone that communicates fullness to the brain, slows digestion, and improves how the body handles glucose
Dose Variability and Efficacy Loss Without HPLC testing or manufacturing controls, two vials sold as 10 mg can contain 5 mg or 15 mg